Clinical Trial Update: CLN-418 Study on Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

The Phase 1 study of CLN-418 in subjects with advanced solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CLN-418

Snippet

Sponsor: Harbour BioMed US, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED